A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Baxter International Inc stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 273,559 shares of BAX stock, worth $9.02 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
273,559
Previous 278,227 1.68%
Holding current value
$9.02 Million
Previous $9.31 Million 11.62%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.85 - $40.26 $153,343 - $187,933
-4,668 Reduced 1.68%
273,559 $10.4 Million
Q2 2024

Jul 22, 2024

SELL
$32.87 - $43.55 $106,958 - $141,711
-3,254 Reduced 1.16%
278,227 $9.31 Million
Q1 2024

May 03, 2024

SELL
$37.88 - $43.77 $81,631 - $94,324
-2,155 Reduced 0.76%
281,481 $12 Million
Q4 2023

Jan 24, 2024

SELL
$31.71 - $38.95 $63,483 - $77,977
-2,002 Reduced 0.7%
283,636 $11 Million
Q3 2023

Oct 23, 2023

SELL
$37.32 - $49.29 $249,036 - $328,912
-6,673 Reduced 2.28%
285,638 $10.8 Million
Q2 2023

Jul 25, 2023

SELL
$39.98 - $47.68 $39,540 - $47,155
-989 Reduced 0.34%
292,311 $13.3 Million
Q1 2023

May 17, 2023

BUY
$37.58 - $52.57 $10.7 Million - $14.9 Million
284,274 Added 3149.5%
293,300 $11.9 Million
Q1 2023

May 15, 2023

SELL
$37.58 - $52.57 $10.6 Million - $14.8 Million
-280,950 Reduced 96.89%
9,026 $366 Million
Q4 2022

Feb 09, 2023

SELL
$49.7 - $57.71 $959,707 - $1.11 Million
-19,310 Reduced 6.24%
289,976 $14.8 Million
Q3 2022

Nov 04, 2022

BUY
$53.86 - $66.8 $278,940 - $345,957
5,179 Added 1.7%
309,286 $16.7 Million
Q2 2022

Aug 10, 2022

BUY
$63.83 - $80.0 $194,809 - $244,160
3,052 Added 1.01%
304,107 $19.5 Million
Q1 2022

Apr 27, 2022

BUY
$76.85 - $89.45 $44,573 - $51,881
580 Added 0.19%
301,055 $23.3 Million
Q4 2021

Jan 31, 2022

SELL
$74.57 - $87.19 $532,056 - $622,100
-7,135 Reduced 2.32%
300,475 $25.8 Million
Q3 2021

Oct 20, 2021

SELL
$73.77 - $83.61 $970,960 - $1.1 Million
-13,162 Reduced 4.1%
307,610 $24.7 Million
Q2 2021

Jul 20, 2021

SELL
$80.5 - $88.01 $1.5 Million - $1.63 Million
-18,575 Reduced 5.47%
320,772 $25.8 Million
Q1 2021

Apr 22, 2021

SELL
$76.38 - $86.03 $2.26 Million - $2.55 Million
-29,628 Reduced 8.03%
339,347 $28.6 Million
Q4 2020

Feb 12, 2021

SELL
$75.39 - $82.36 $653,103 - $713,484
-8,663 Reduced 2.29%
368,975 $29.6 Million
Q3 2020

Nov 06, 2020

SELL
$78.33 - $90.73 $2.79 Million - $3.23 Million
-35,632 Reduced 8.62%
377,638 $30.4 Million
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $1.9 Million - $2.27 Million
-24,151 Reduced 5.52%
413,270 $35.6 Million
Q1 2020

May 13, 2020

BUY
$71.57 - $93.3 $491,256 - $640,411
6,864 Added 1.59%
437,421 $35.5 Million
Q4 2019

Feb 12, 2020

BUY
$76.7 - $88.45 $20,325 - $23,439
265 Added 0.06%
430,557 $36 Million
Q3 2019

Nov 20, 2019

BUY
$81.4 - $89.78 $2.48 Million - $2.74 Million
30,516 Added 7.63%
430,292 $37.6 Million
Q2 2019

Aug 14, 2019

SELL
$73.44 - $82.41 $112,583 - $126,334
-1,533 Reduced 0.38%
399,776 $32.7 Million
Q1 2019

May 13, 2019

SELL
$64.48 - $81.31 $628,808 - $792,935
-9,752 Reduced 2.37%
401,309 $30.7 Million
Q4 2018

Feb 14, 2019

SELL
$61.45 - $77.8 $41,110 - $52,048
-669 Reduced 0.16%
411,061 $27.1 Million
Q3 2018

Oct 23, 2018

SELL
$70.71 - $77.75 $464,706 - $510,973
-6,572 Reduced 1.57%
411,730 $31.7 Million
Q2 2018

Aug 02, 2018

SELL
$63.43 - $75.41 $352,036 - $418,525
-5,550 Reduced 1.31%
418,302 $30.9 Million
Q1 2018

Apr 10, 2018

SELL
$62.56 - $72.26 $967,678 - $1.12 Million
-15,468 Reduced 3.52%
423,852 $27.6 Million
Q4 2017

Jan 22, 2018

SELL
$61.45 - $66.05 $1.17 Million - $1.26 Million
-19,098 Reduced 4.17%
439,320 $28.4 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $27.3 Million - $29.6 Million
458,418
458,418 $28.8 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.